Identification of xanthine oxidase inhibitors through hierarchical virtual screening

As a critical enzyme for the uric acid production, xanthine oxidase (XO) has emerged as a primary drug target for antihyperuricemic therapy. A hierarchical virtual screening integrating both ligand-based and structure-based approaches was applied herein to identify potent XO inhibitors. Four compounds, which were previously reported as XO inhibitors, were recognized through the virtual screening protocol, and compoundH3, which is distinct from the structures of known XO inhibitors, was identified as a new chemotype inhibitor with IC(50)of 2.6 mu M. The binding mode ofH3was further investigated by molecular docking and molecular dynamics (MD) simulation. The results suggested the feasibility to discover new chemotypes of XO inhibitorsviaintegrated virtual screening strategies.